基本信息
浏览量:197
职业迁徙
个人简介
Andrew Nixon, PhD, MBA (Associate Professor of Medicine) is Director of the Phase I Biomarker Laboratory, which brings together clinical, translational and basic research to pursue the development of novel biomarkers defining mechanisms of sensitivity, resistance, and toxicity to given therapeutic drug classes, particularly anti-angiogenic agents. Additionally, the laboratory has been appointed as a Molecular Reference Laboratory for the Alliance oncology cooperative group, a national clinical trial research group sponsored by the National Cancer Institute. The laboratory has quality control procedures in place to address many of the issues involved in clinical trial research including determination of sample quantity, sample integrity, and sample heterogeneity. We have spent considerable time developing robust assays that utilize limited amounts of specimen while providing high quality data. Multiplex ELISA and gene expression arrays are used to analyze serially collected blood and paraffin samples archived from cancer patient clinical trials. This work has the potential to improve the efficacy and toxicity of current therapies and to guide the development of the next generation of anti-angiogenesis therapies for cancer and other diseases.
Selected Grants and Awards
Preclinical and Human Correlative Studies of a Novel Bruton Tyronsine Kinase Inhibitor in Pancreatic Cancer
Dovitinib in Treating Patients with Recurrent or Progressive Glioblastoma
The role of Claudin-2 in metastatic colorectal cancer
Immune signatures in metastatic colorectal cancer
RAP-041 mediated modulation of intratumoral immune cell subpopulations in vivo and effect of combination treatment with anti-PD1 monoclonal antibody
Anti-endoglin mediated modulation of intratumoral Immune Cell Subpopulationg in vivo and effoect of combination treatment with anti-PD1 monoclonal antibodies
CTOT - Cell Free DNA
Predictive value of the IL6 pathway to direct anti-angiogenic therapy in advanced ovarian cancer
Blood-based Biomarker Profiling for TEW-7197
Blood-based Angiome Profiling to Direct Bevacizumab Therapy in Ovarian Cancer
Janssen Research AGreement
The prevalence of MET gene amplification in metastatic colorectal cancer
Serum Biomarkers in Lymphoma
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'
Anti-VEGF in Tumors & Wounds: Efficacy vs Toxicity
New Clinical Biomarker for Cancer--Wound Angiogenesis
Regulation Of Cyclic Gmp Phosphodiesterase By Gz
Selected Grants and Awards
Preclinical and Human Correlative Studies of a Novel Bruton Tyronsine Kinase Inhibitor in Pancreatic Cancer
Dovitinib in Treating Patients with Recurrent or Progressive Glioblastoma
The role of Claudin-2 in metastatic colorectal cancer
Immune signatures in metastatic colorectal cancer
RAP-041 mediated modulation of intratumoral immune cell subpopulations in vivo and effect of combination treatment with anti-PD1 monoclonal antibody
Anti-endoglin mediated modulation of intratumoral Immune Cell Subpopulationg in vivo and effoect of combination treatment with anti-PD1 monoclonal antibodies
CTOT - Cell Free DNA
Predictive value of the IL6 pathway to direct anti-angiogenic therapy in advanced ovarian cancer
Blood-based Biomarker Profiling for TEW-7197
Blood-based Angiome Profiling to Direct Bevacizumab Therapy in Ovarian Cancer
Janssen Research AGreement
The prevalence of MET gene amplification in metastatic colorectal cancer
Serum Biomarkers in Lymphoma
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'
Anti-VEGF in Tumors & Wounds: Efficacy vs Toxicity
New Clinical Biomarker for Cancer--Wound Angiogenesis
Regulation Of Cyclic Gmp Phosphodiesterase By Gz
研究兴趣
论文共 282 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Prostate Cancer and Prostatic Diseasespp.1-8, (2024)
bioRxiv : the preprint server for biology (2023)
Helen Mackay,Andrew B. Nixon,Danielle Enserro,David Bender, B. J. Rimel,Matthew A. Powell,Debra L. Richardson,Laura L. Holman, Nitya Alluri,Cara Amanda Mathews,Ruchi Garg, Sarah Gill,
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 5525-5525
引用0浏览0引用
0
0
Communications Medicineno. 1 (2023): 1-7
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 4040-4040
引用0浏览0引用
0
0
Kamran Mahmood, Parvathi Jampani,Jeffrey M Clarke,Steven Wolf,Xiaofei Wang,Momen M Wahidi,Coral X Giovacchini,Michael Dorry,Scott L Shofer, Jessica Shier,Greg Jones,Scott J Antonia,
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 3533-3533
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn